Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




CT Homepage

New approach identifies lung cancer patients most likely to respond to chemotherapy Combines radiomics and CT image assessment

BSWH to install Glassbeam's CLEAN blueprint to leverage machine uptime Will include integrated CMMS software by EQ2

Siemens to unveil its SOMATOM go.Top Cardiovascular Edition CT at ACC 19 Ideal for the cardiovascular outpatient setting

Hitachi unveils new CT and ultrasound solutions at ECR Standard version of SCENARIA VIEW and three new Arietta ultrasound solutions

Canon showcases CT image reconstruction tech and software upgrade at ECR Removing noise while preserving signals

Universal measurement approach to CT X-ray proposed by researchers 'Only a small change to existing practice is required to unify their measurements.'

Philips debuts Incisive CT at ECR Includes industry-first "Tube for Life" guarantee policy

Personalized cardiac test could eliminate unnecessary catheterizations Examines flow of blood with AI and CT

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

Siemens focuses on digitalization at HIMSS Its expanded digital service portfolio will be on display

A new technique promises to cut down
the rate of false positives in lung
cancer diagnoses, without missing
a single case of cancer

Machine learning reduces false positives for lung cancer in low-dose CT

by John R. Fischer , Staff Reporter
While the standard diagnostic test for early detection of lung cancer in those at high-risk, low-dose CT produces false positives at a rate of 96 percent. That may soon change with a new technique developed at the University of Pittsburgh and UPMC Hillman Cancer Center.

Using machine learning, researchers were able to reduce false positives while still identifying every case that carried a malignancy, a feat they claim is the first example in which AI has been used to differentiate benign from cancerous nodules in lung cancer screenings.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

"This concept is the wave of the future in clinical decision-making for indeterminant lung nodules, and will hopefully include a blood test or something similar in the near future," senior author David Wilson, associate professor of medicine, cardiothoracic surgery and clinical and translational science at Pitt and co-director of the Lung Cancer Center at UPMC Hillman, told HCB News.

Shadows indicating the presence of nodules appear on a quarter of screenings throughout the U.S., but only four percent are actually cancerous. Scans alone cannot indicate who falls into this category, making clinicians hesitant to rule out cancer and leading to greater anxiety among patients as they undergo more costly, additional tests that can carry risks.

Feeding the data of 218 high-risk patients at UPMC into a machine learning algorithm, researchers constructed a model to calculate the probability of cancer. The model relied on the number of blood vessels surrounding the nodule, the number of nodules, and the numbers of years since the patient quit smoking as its most important factors, ruling out cancer if its probability fell below a certain threshold.

"These three features carry the most information about cancer status [of] all other variables," study coauthor Panayiotis (Takis) Benos, professor and vice chair of computational and systems biology and associate director of the Integrative Systems Biology Program at the University of Pittsburgh, told HCB News. "Also the information in each of them is complementary to the other two. Cancer typically needs more energy, so increased vasculature around a nodule has been correlated with cancer. Also the more years since [the subject] quit smoking, the less likely the module is cancerous."

Confirmation as to whether the patients had benign nodules or lung cancer was made later and compared to the model’s assessment. The comparison showed that 30 percent of those with benign nodules could have been spared additional testing, without missing a single case of cancer.

The researchers plan to examine the technique in a larger group. That study, involving 6,000 scans from the National Lung Screening Trial, is currently underway.

The findings were published in the journal, Thorax.

CT Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.